Samir Devalaraja

Samir Devalaraja, MD/PhD, is an Analyst at Avoro Capital Advisors in New York, NY, having joined the firm in 2021. At Avoro, he specializes in evaluating investment opportunities within the biotechnology sector, focusing on innovative therapeutic areas including gene therapy and precision oncology.

He holds both a Doctor of Medicine and a Ph.D. in Immunology from the Perelman School of Medicine at the University of Pennsylvania, where he received the Saul Winegrad Award for outstanding dissertation; his research, which uncovered a novel immune evasion mechanism in solid tumors, was published in Cell. Concurrent with his graduate studies, Samir served as a consultant for venture-backed biotech companies, providing scientific diligence and strategic guidance in areas such as gene therapy and oncology.

Samir also earned a BA in History and Sociology of Science from the University of Pennsylvania, underlining his interdisciplinary expertise. His contributions to the investment industry include leveraging deep scientific training to deliver rigorous biotechnology due diligence and support Avoro’s public and private market strategies, especially in high-science, therapeutics-focused biotech.